| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Feb―03 |
Regorafenib as a potential drug for severe COVID-19: inhibition of inflammasome activation in mice |
Ju Hwan Jeong, Sun-Ok Kim, Seong Cheol Min, Eung-Gook Kim, Min-Suk Song, Eun-Young Shin |
| 2 |
[GO] |
2024―Dec―30 |
Enhancing human ACE2 expression in mouse models to improve COVID-19 research |
Sun Jiaoyang, Cheng Shaofei, Hong Guangliang, Quan Xiongzhi, Lin Haofeng, Mao Rui, Johannes Grillari, Shi Zheng-Li, Chen Jiekai, Liu Meiqin, Wu Haoyu, Wu Guangming |
| 3 |
[GO] |
2023―Dec―22 |
Expression and purification of the receptor-binding domain of SARS-CoV-2 spike protein in mammalian cells for immunological assa |
Edit Ábrahám, Csaba Bajusz, Annamária Marton, Attila Borics, Thandiswa Mdluli, Norbert Pardi, Zoltán Lipinszki |
| 4 |
[GO] |
2023―Sep―22 |
Cell-specific genome-scale metabolic modeling of SARS-CoV-2-infected lung to identify antiviral enzymes |
Ke-Lin Chen, Feng-Sheng Wang |
| 5 |
[GO] |
2022―Nov―23 |
Thermodynamic analysis of the interactions between human
ACE2
and Spike
RBD
of Betacoronaviruses (
SARS-CoV
-1 and
SARS-CoV
-2) |
Agnieszka Rombel-Bryzek, Adriana Miller, Danuta Witkowska |
| 6 |
[GO] |
2022―Oct―22 |
Transcriptional dynamics of granulocytes in direct response to incubation with
SARS-CoV
-2 |
Daigo Nakazawa, Yohei Takeda, Masatoshi Kanda, Utano Tomaru, Haruko Ogawa, Takashi Kudo, Satoka Shiratori-Aso, Kanako Watanabe-Kusunoki, Yusho Ueda, Atsuko Miyoshi, Fumihiko Hattanda, Saori Nishio, Ryo Uozumi, Akihiro Ishizu, Tatsuya Atsumi |
| 7 |
[GO] |
2022―Sep―01 |
Structural investigations of proteins encoded by
SARS-CoV
-2 |
Alexander Wlodawer |
| 8 |
[GO] |
2022―Aug―25 |
Cotton flower metabolites inhibit
SARS-CoV
-2 main protease |
Yufang Zhang, Wenkang Li, Yiming Hu, Tianze Ding, Mubashar Zafa, Xue Jia, Liya Zhang, Maozhi Ren, Fuguang Li, Wenjing Wang |
| 9 |
[GO] |
2022―Jun―11 |
The spike glycoprotein of highly pathogenic human coronaviruses: structural insights for understanding infection, evolution and inhibition |
Shuyuan Qiao, Shuyuan Zhang, Jiwan Ge, Xinquan Wang |
| 10 |
[GO] |
2022―Apr―21 |
Recent insights into the structure and function of coronavirus ribonucleases |
Meredith N. Frazier, Amanda A. Riccio, Isha M. Wilson, William C. Copeland, Robin E. Stanley |
| 11 |
[GO] |
2022―Apr―16 |
Viral and cellular translation during SARS-CoV-2 infection |
Gilbert Eriani, Franck Martin |
| 12 |
[GO] |
2021―Dec―01 |
Evaluating cepharanthine analogues as natural drugs against SARS-CoV-2 |
Atsushi Hijikata, Clara Shionyu-Mitsuyama, Setsu Nakae, Masafumi Shionyu, Motonori Ota, Shigehiko Kanaya, Takatsugu Hirokawa, Shogo Nakajima, Koichi Watashi, Tsuyoshi Shirai |
| 13 |
[GO] |
2021―Oct―06 |
Seasonal UV exposure and vitamin D: Association with the dynamics of COVID-19 transmission in Europe |
Sunanda Biswas Mukherjee, Alessandaro Gorohovski, Eugene Merzon, Eliad Levy, Sumit Mukherjee, Milana Frenkel-Morgenstern |
| 14 |
[GO] |
2020―Sep―24 |
An investigation into the molecular basis of cancer comorbidities in coronavirus infection |
Antonio Facchiano, Francesco Facchiano, Angelo Facchiano |
| 15 |
[GO] |
2020―May―06 |
Potential anti-SARS-CoV-2 drug candidates identified through virtual screening of the ChEMBL database for compounds that target the main coronavirus protease |
Motonori Tsuji |
